BIOMAT Database Logo BIOMAT Database Logo

Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide. 1988

M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Department of Chemistry, University of Oklahoma, Norman 73019.

Didemnin B, a highly active depsipeptide isolated from a Caribbean tunicate, crystallizes from chloroform/benzene in the orthorhombic space group C2221, with cell parameters a = 14.990 +/- 0.003 A, b = 22.574 +/- 0.004 A, c = 41.112 +/- 0.009 A, V = 13911.7 A3 at 138 K and a calculated density of 1.143 g/cm3 based on C57H89N7O15, 1.5C6H6.H2O and eight formula units per cell. The overall agreement factor R = 0.052 for 7699 reflections, 20 theta max = 150 degrees, Cu K-alpha radiation. The structure determination revealed that didemnin B contains an isostatine residue instead of a statine residue. The conformation of the 23-membered depsipeptide ring is stabilized by one transannular hydrogen bond. The ring does not show the antiparallel beta-pleated-sheet structure but, instead, has a fold in the shape of a bent figure-eight. The linear peptide moiety, containing N-methylleucine and lactylproline, forms a beta (II)-bend and is folded back toward the cyclic backbone, giving the overall molecule a globular character. Comparison with the structure of cyclosporin A shows distinct stereochemical differences between the two molecules. It is suggested that didemnin B and cyclosporin A are unlikely to have a common receptor binding site.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D047630 Depsipeptides Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized. Cyclic Depsipeptide,Cyclodepsipeptide,Depsipeptide,Peptolide,Peptolides,Cryptophycins,Cyclodepsipeptides,Depsipeptides, Cyclic,Cyclic Depsipeptides,Depsipeptide, Cyclic

Related Publications

M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Didemnin B. Conformation and dynamics of an antitumour and antiviral depsipeptide studied in solution by 1H and 13C. n.m.r. spectroscopy.
December 1989, International journal of peptide and protein research,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Mechanism of action of didemnin B, a depsipeptide from the sea.
July 1984, Cancer letters,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B.
November 2011, Journal of natural products,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide.
November 1988, European journal of cancer & clinical oncology,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Abi Family Protein, DidK, Is Involved in the Maturation of Anticancer Depsipeptide, Didemnin B.
October 2023, ACS chemical biology,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Crystal and molecular structure of Destruxin B.
February 1988, International journal of peptide and protein research,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
The crystal structure of an LLL-configured depsipeptide substrate analogue bound to isopenicillin N synthase.
January 2010, Organic & biomolecular chemistry,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
A concise route to the proposed structure of lydiamycin B, an antimycobacterial depsipeptide.
December 2009, Organic letters,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Crystal structure of human ISG20, an interferon-induced antiviral ribonuclease.
November 2004, FEBS letters,
M B Hossain, and D van der Helm, and J Antel, and G M Sheldrick, and S K Sanduja, and A J Weinheimer
Crystal structure of monkeypox H1 phosphatase, an antiviral drug target.
June 2023, Protein & cell,
Copied contents to your clipboard!